Your goal is to protect and support your patient along their surgical journey, hospital stay or clinic visit. We are here to help address your challenges with leading innovations in negative pressure wound therapy (NPWT), surgical incision management, infection prevention, advanced wound care and skin integrity to help meet the needs of the people you care for every day.
No matter your patients’ needs, we are with you and your team every step of the way. We provide you with innovative products that are rooted in clinical evidence, helping you accelerate patient healing and drive more effective outcomes.
Timely incision management can help reduce the human and economic costs of SSIs. Learn how to get the right care to your patients at the right time. Explore how we can help you manage and protect surgical incisions in high risk patients.
Every wound is unique and may require a cascading approach to treatment. NPWT creates an environment that promotes wound healing by delivering negative pressure at the wound site. 3M offers a range of these specialized solutions to support your individual facility and patient needs.
Facility-acquired pressure injuries are a growing healthcare problem which can lead to longer hospital stays and higher readmission rates. Explore resources to help determine if your wound management system supports skin and protects patients from preventable complications.¹
With a range of course topics like building a skin damage prevention team to addressing VLUs with compression therapy, deepen your expertise through professional training opportunities and educational resources designed just for you.
See the impact of the first disposable powered negative pressure system designed specifically for the management of closed surgical incisions.
For 35 years, clinicians have been working with 3M™ Tegaderm™ Dressings, and clinician insights inspiring 3M scientists with its very invention. We continue to collaborate with health care professionals from around the world to develop products that help keep patients protected and prevent the risks of costly complications.
More than 90 percent of chronic wounds contain bacteria and fungi bioburden.2 3M™ Veraflo™ Therapy allows you to cleanse the wound and promote granulation tissue formation at the same time.
Explore new evidence illustrating the clinical efficacy of 3M™ Veraflo™ Therapy.
Simplify your skin integrity needs with 3M™ Cavilon™ Skin Care Solutions. With an advanced skin protectant, novel barriers, and skin cleansers, lotions and creams, find optimal solutions to manage and protect at-risk skin.
For 25 years, 3M™ V.A.C.® Therapy has been shown to be a successful way to manage wounds and support healing. Explore how 3M delivers the innovative negative pressure wound therapy technology and evidence-based outcomes you need with the safety and confidence your patients can trust.
Early first-line intervention with the 3M™ Snap™ Therapy System in an outpatient setting supports healing while helping to return patients to normal daily activities. The 3M™ Snap™ Therapy System combines the simplicity of advanced wound dressings with the proven benefits3 of negative pressure wound therapy (NPWT) in a discreet, highly mobile design.
An error has occurred while submitting. Please try again later...
Your form was submitted successfully
Subscribe to receive the latest 3M news, events and information.
An error has occurred while submitting. Please try again later...
Your form was submitted successfully
References
1. Zaratkiewicz, S., Whitney, J. D., Lowe, J. R., Taylor, S., O'Donnell, F., & Minton-Foltz, P. (2010). Development and Implementation of a Hospital-Acquired Pressure Ulcer Incidence Tracking System and Algorithm. Journal for Healthcare Quality, 32(6), 44-51
2. Attinger C, Wolcott R. Clinically Addressing Biofilm in Chronic Wounds. Adv Wound Care. 2012;1(3):127‐132. doi:10.1089/wound.2011.0333
3. Armstrong DG, Marston WA, Reyzelman AM, Kirsner RS. Comparative effectiveness of mechanically and electrically powered negative pressure wound therapy devices: a multicenter randomized controlled trial. Wound Rep Reg 2012; 20(3):332-341.